Leede Financial analyst Douglas Loe cut his target on Cardiol Therapeutics (Cardiol Therapeutics Stock Quote, Chart, News, Analysts, Financials TSX:CRDL, NASDAQ:CRDL) to $7.00 from $11.00 while maintaining a “Speculative Buy” after the company released fuller Phase II ARCHER data in acute myocarditis. The 109-patient study, presented at a cardiology meeting in Italy, tested Cardiol’s oral […]
Roth Capital Markets analyst Boobalan Pachaiyappan said in a Nov. 25 report that Capricor Therapeutics’ (Capricor Therapeutics Stock Quote, Chart, News, Analysts, Financials NASDAQ:CAPR) sharp decline on Nov. 24 — a 19% drop versus a 3% gain for the S&P’s biotech ETF XBI — was driven by a short seller’s note that questioned the profile […]
Share
Tweet
Share
